|
mrna metabolic process
|
GO:0016071 |
84 |
0.568
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.517
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.455
|
|
|
histone modification
|
GO:0016570 |
159 |
0.291
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.277
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.236
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.228
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.174
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.173
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.162
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.162
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.155
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.151
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.150
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.137
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.126
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.121
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.121
|
|
|
rna processing
|
GO:0006396 |
105 |
0.097
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.092
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.091
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.088
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.071
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.068
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.066
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.065
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.062
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.062
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.062
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.061
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.060
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.059
|
|
|
rna interference
|
GO:0016246 |
2 |
0.059
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.059
|
|
|
regulation of cell cycle checkpoint
|
GO:1901976 |
9 |
0.053
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.051
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.048
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.046
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.045
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.044
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.044
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.043
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.043
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.041
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.041
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.041
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.039
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.039
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.039
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.038
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.036
|
|
|
dna repair
|
GO:0006281 |
107 |
0.036
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.035
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.035
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.034
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.033
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.033
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.033
|
|
|
methylation
|
GO:0032259 |
134 |
0.033
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.033
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.033
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.032
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.032
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.032
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.031
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.031
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.030
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.030
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
habituation
|
GO:0046959 |
3 |
0.029
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
cell division
|
GO:0051301 |
120 |
0.028
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.027
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.026
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.026
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.026
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.026
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.026
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.026
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.025
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.025
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.025
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.025
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.025
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.024
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
regionalization
|
GO:0003002 |
337 |
0.024
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.024
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.024
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
gonad development
|
GO:0008406 |
141 |
0.024
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.023
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.023
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.023
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.023
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.023
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.023
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.023
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.023
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.022
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.022
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.022
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.022
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.022
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.022
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.022
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.022
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.021
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.021
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.021
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.021
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.021
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.020
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.020
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.020
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.020
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.020
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.019
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.019
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.019
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.019
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
negative regulation of dna dependent dna replication
|
GO:2000104 |
1 |
0.018
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.018
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.018
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.017
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.017
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.017
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.017
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.017
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.017
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.016
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.016
|
|
|
ear development
|
GO:0043583 |
200 |
0.016
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.016
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.016
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.016
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.015
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.015
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.015
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.015
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.015
|
|
|
cation transport
|
GO:0006812 |
399 |
0.015
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.015
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.015
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.015
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.015
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.015
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.015
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.014
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.014
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.014
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.014
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.014
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.014
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.014
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.014
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.014
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.014
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.014
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.014
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.014
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.014
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.013
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.013
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.013
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.013
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.013
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.013
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.013
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.013
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.013
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.013
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.012
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.012
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.012
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.012
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.012
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.012
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.012
|
|
|
translation
|
GO:0006412 |
93 |
0.012
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.012
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.012
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.012
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.012
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.012
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.012
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.012
|
|
|
regulation of rna export from nucleus
|
GO:0046831 |
4 |
0.012
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.012
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.012
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.011
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.011
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.011
|
|
|
lung development
|
GO:0030324 |
164 |
0.011
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.011
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.011
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.011
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.011
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.011
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.011
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.011
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.011
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.011
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.011
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.011
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.011
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.011
|
|
|
ossification
|
GO:0001503 |
216 |
0.011
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.011
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.011
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.011
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.011
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.011
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.011
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.010
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.010
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.010
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.010
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.010
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.010
|
|
|
placenta development
|
GO:0001890 |
140 |
0.010
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.010
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.010
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.010
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.010
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.010
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.010
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.010
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.010
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.010
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.010
|
|